Moderate Aplastic Anemia: A Treatment Dilemma | Aplastic Anemia & MDS International Foundation

Moderate Aplastic Anemia: A Treatment Dilemma

Topic(s): 
Aplastic Anemia
Presentation Date: 
Thursday, August 6, 2020

Swapna Thota, MD joined Roswell Park in 2017 where she specializes in caring for patients with acute leukemias, MDS and other blood cancers. She holds a dual appointment as Assistant Professor of Oncology at Roswell Park Comprehensive Cancer Center and Jacobs School of Medicine and Biomedical Sciences, State University of New York at Buffalo.  Dr. Thota's research focuses on hematologic malignancies, especially on novel drug development to improve outcomes in patients with blood cancers. 

Dr. Thota discusses the complexities of determining the best course of treatment for patients with moderate aplastic anemia